Videos | Cardio-oncology

American Heart Association (AHA) released a scientific statement Feb. 1, 2018, linking breast cancer and cardiovascular ...

Home February 01, 2018
Home
News | Stroke

February 1, 2018 – EmboTrap Device, a device designed to remove clots from the brain following an ischemic stroke ...

Home February 01, 2018
Home
Laxmi Mehta, M.D., reviews an echocardiogram at The Ohio State Wexner Medical Center for a cardio-oncology cancer patient to look for heart damage caused by chemotherapy or radiation therapy.
Feature | Cardio-oncology

February 1, 2018 – Heart disease and breast cancer are two of the most prevalent diseases among women in the United ...

Home February 01, 2018
Home
News | Heart Failure

February 1, 2018 – In evaluating the quality of care given to those hospitalized with heart failure, adherence to ...

Home February 01, 2018
Home
News | Cardiovascular Clinical Studies

February 1, 2018 – LimFlow SA, developer of minimally-invasive technology for the treatment of end-stage critical limb ...

Home February 01, 2018
Home
News | Mobile Devices

Zebra Technologies Corp. announced the results of its Future of Healthcare: 2022 Hospital Vision Study, revealing the impact of mobile technology use in acute care hospitals. The research — which incorporates feedback from nursing managers, information technology (IT) decision-makers and patients — offers a perspective from the front-line of patient care. It also highlights the transformational power clinical mobility is expected to have on global health services within the next five years.

Home January 31, 2018
Home
ACC 2018 highlights and trends.  #acc.18, #ACC, #ACC2018
Feature | ACC

The rapid pace of change continues to be a hallmark in cardiovascular medicine and many see that pace accelerating. In ...

Home January 31, 2018
Home
Feature | Sudden Cardiac Arrest

January 31, 2018 — Overall survival has improved for the about 200,000 patients experiencing in-hospital cardiac arrest ...

Home January 31, 2018
Home
News | Cardiovascular Business

January 30, 2018 — Amazon , Berkshire Hathaway and JPMorgan Chase & Co. announced that they are partnering on ways to ...

Home January 30, 2018
Home
News | Cath Lab

The Society for Cardiovascular Angiography and Interventions (SCAI) highlighted the efforts of its Advocacy Committee in 2017 to push healthcare reform forward, spotlighting the committee’s role in protecting reimbursement rates for interventional cardiology procedures.

Home January 30, 2018
Home
News | Cardiovascular Ultrasound

January 29, 2018 — The American Society of Echocardiography (ASE) announced that ImageGuideEcho, a module under the ...

Home January 29, 2018
Home
Videos | Wearables

Take a video tour of some of the medical devices designed to improve patient care, improve patient engagement and ...

Home January 29, 2018
Home
News

January 26, 2017 — Results from a core lab analysis from the PROMISE Trial on cardiac computed tomography (CT) were ...

Home January 29, 2018
Home
News | EP Lab

January 26, 2018 — LivaNova PLC and MicroPort Scientific Corp. announced the companies have entered into a binding ...

Home January 26, 2018
Home
News | Venous Therapies

Medtronic plc announced the initiation of its investigational device exemption (IDE) study for the Abre venous self-expanding stent system. The ABRE IDE Study will evaluate the safety and effectiveness of the Abre stent in subjects with iliofemoral venous outflow obstruction. The first procedure was performed in December of 2017, by Erin Murphy, M.D., director of the venous and lymphatic program at Carolinas HealthCare System’s Sanger Heart & Vascular Institute in Charlotte, N.C., and national principal investigator for the ABRE IDE Study in the United States.

Home January 26, 2018
Home
Subscribe Now